Comments on ICER’s Draft Evidence Report: High Cholesterol Therapies
Effective treatments that reduce the risk factors associated with ASCVD offers tremendous value to the patient community. Read the Letter
Migraine Disease: Then and Now
By Mary Franklin, MA – This fall, Congress introduced a first-of-its-kind resolution that acknowledged the ways migraine disease affects millions of Americans.
The Cards Seniors Won’t Receive This Holiday
The holiday season is synonymous with sending and receiving cards. But there’s one card many seniors won’t have in hand this holiday: a co-pay card.
Health Data Gaps Widen Racial Divide
Holes in clinical trials data could be keeping people of color from accessing the medication they need.
Getting a Grip on Gout
Gout has quickly become a problem of global proportion.
Lawmakers & Regulators Tackle “Bad Drug” Ads
“Bad drug” ads often target seniors with misinformation about prescription medications, with their scare tactics costing viewers their health – even their lives.
Alzheimer’s Patients Need Something to Cheer About
It’s looking like a lonely holiday season for people living with Alzheimer’s disease and their caregivers.
Congress Aims to Expand Access to Clinical Trials
New legislation could make it easier for people to participate in clinical trials regardless of their economic situation.
The Eye Disease Hidden in Plain Sight
The disease most likely to lead to blindness remains largely unknown to most Americans, a recent study shows.
Is Health Care Access a Losing Battle for Veterans?
Accessing proper health care can be a tough fight for America’s veterans. Those living with a rare disease called amyloidosis provide a telling example.
